EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Non‐invasive risk stratification of congenital cytomegalovirus infection using extracellular vesicle biomarkers

Lierni Ugartemendia, Brenna L. Hughes, Robert Suchting, Menna Elsaka, Gail J. Demmler‐Harrison, Laura Goetzl

Pregnancy · 2026-11 · 2 (6)

DOI: 10.1002/pmf2.70495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pregnancy, online erschienen am 16.11.2026. Verfasst von Lierni Ugartemendia und 5 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Child Health and Human Development, National Center for Advancing Translational Sciences, National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cytomegalovirus (CMV) is one of the most common infections during pregnancy and can result in congenital CMV (cCMV) infection and long‐term sequelae. In utero diagnosis of cCMV requires amniocentesis. In this nested case–control study, we investigated the use of fetal neuronally derived extracellular vesicles (fNEVs) in maternal circulation to characterize fetal brain alterations following primary maternal infection and evaluate their association with cCMV infection and disease severity.

Methods

We used stored plasma samples from women enrolled in a multicenter randomized trial of CMV hyperimmune globulin (CMV‐HIG) ( n = 98). We isolated fNEVs from maternal plasma prior to treatment randomization (Gestational age: 20.04 ± 4.2 weeks) and 8 weeks later, and measured EV biomarkers of neuronal injury/injury response: synaptopodin (SYNPO) and Bcl‐2‐associated factor 1 (BCLAF1), both normalized to the EV marker CD81. We assessed the associations of these biomarkers with neonatal infection or symptomatic status using generalized linear mixed models and predictive performance analysis.

Results

Fetal CMV infection was associated with higher pre‐randomization levels of fNEV SYNPO ( p = 0.001) and BCLAF1 ( p = 0.040). BCLAF1 levels were also higher in symptomatic subjects ( p = 0.029) pre‐randomization. The combined SYNPO/BCLAF1 model demonstrated modest discrimination for fetal infection (area under the curve [AUC] = 0.713; 95% confidence interval [CI] = [0.612, 0.815]). We observed a decrease in SYNPO levels over time in symptomatic cCMV ( p = 0.006). In symptomatic subjects those exposed to CMV‐HIG had higher SYNPO levels than the placebo group ( p = 0.004). Commonly, acute injury is associated with decreased levels of SYNPO, while increased SYNPO suggests a chronic response/repair state. Taken together, our findings suggest that noninvasive risk‐stratification of CMV infection/symptomatic infection may be possible with testing refinement.

Förderung

  • National Institute of Child Health and Human Development
  • National Center for Advancing Translational Sciences
  • National Institutes of Health

Zitieren

APA

Ugartemendia, L., Hughes, B. L., Suchting, R., Elsaka, M., Demmler‐Harrison, G. J., & Goetzl, L. (2026). Non‐invasive risk stratification of congenital cytomegalovirus infection using extracellular vesicle biomarkers. Pregnancy, 2(6). https://doi.org/10.1002/pmf2.70495

Vancouver

Ugartemendia L, Hughes BL, Suchting R, Elsaka M, Demmler‐Harrison GJ, Goetzl L. Non‐invasive risk stratification of congenital cytomegalovirus infection using extracellular vesicle biomarkers. Pregnancy. 2026;2(6). doi:10.1002/pmf2.70495

BibTeX
@article{Ugartemendia2026,
  author = {Ugartemendia, Lierni and Hughes, Brenna L. and Suchting, Robert and Elsaka, Menna and Demmler‐Harrison, Gail J. and Goetzl, Laura},
  title = {Non‐invasive risk stratification of congenital cytomegalovirus infection using extracellular vesicle biomarkers},
  journal = {Pregnancy},
  year = {2026},
  volume = {2},
  number = {6},
  doi = {10.1002/pmf2.70495}
}
Kostenlos starten →